NewsBytes
    Hindi
    More
    In the news
    Supreme Court Of India
    Central Bureau Of Investigation (CBI)
    Indian Army
    Indian Railways
    Indian Air Force
    NewsBytes
    Hindi
    NewsBytes
    User Placeholder

    Hi,

    Logout


    India Business World Politics Sports Technology Entertainment Auto Lifestyle Inspirational Career Bengaluru Delhi Mumbai Visual Stories Find Cricket Statistics Phones Reviews Fitness Bands Reviews Speakers Reviews

    Download Android App

    Follow us on
    • Facebook
    • Twitter
    • Linkedin
     
    Home / News / India News / India likely to have COVID-19 vaccine by December: Adar Poonawalla
    India

    India likely to have COVID-19 vaccine by December: Adar Poonawalla

    India likely to have COVID-19 vaccine by December: Adar Poonawalla
    Written by Shubham Sharma
    Aug 11, 2020, 07:05 pm 3 min read
    India likely to have COVID-19 vaccine by December: Adar Poonawalla

    India should have a vaccine to exit the COVID-19 pandemic by the end of this year. The claim comes directly from Adar Poonawalla, the Chief Executive of Serum Institute of India, the organization racing to mass-manufacture and distribute potential vaccine candidates developed to fight the deadly respiratory disease. Here's all you need to know about it.

    Candidates moving toward trials, should launch by December

    In a recent conversation with CNBC-TV18, Poonawalla said that one of their candidate vaccines against COVID-19, the ChAdOx1 nCoV-19 from Oxford University/AstraZeneca, should be available in India by December. "We are going to start trials in less than two weeks...The trial is in partnership with ICMR," Poonawalla said, noting that "We will start manufacturing vaccines by the end of August."

    Trials will have 4,000-5,000 volunteers

    The trials in question, as Poonawalla explained, are part of a broader Phase-2/3 study, which has been cleared by Drug Controller General of India and will have 4,000-5,000 local volunteers. They will be given two doses of the vaccine four weeks apart; the resulting data will be correlated with that collected from foreign trials of the shot to confirm safety and efficacy by November.

    Manufacturing being funded by Bill & Melinda Gates Foundation

    Poonawalla said they will begin at-risk vaccine manufacturing by the end of August to ensure sufficient supply by the time of approval, distribution. He said that the total cost of manufacturing is $250 million, of which $150 million has been funded by the Bill & Melinda Gates Foundation through GAVI, the vaccine alliance. This way, Serum doesn't have to foot the whole manufacturing bill.

    100 million doses for low-income countries by 2021

    Under the partnership with Gates Foundation, Serum Institute has agreed to manufacture and deliver up to 100 million COVID-19 vaccine doses for up to 90 low-income countries, including India, by 2021. Poonawalla had previously said the company plans to manufacture 300-400 million doses by year-end.

    Cost would be around Rs. 250/dose

    When announcing the partnership with Gates Foundation, Serum Institute had also said that it will sell the shots at a special price of $3/dose (Rs. 250). However, in the interview, Poonawalla clarified the shot could get a "dollar or two" more expensive than the quoted value after licensing. We will know the final pricing in two months, he added.

    Oxford vaccine has shown promise in early-stage trials

    The Oxford vaccine, although not yet approved, has shown promise in early-stage trials by safely generating "dual immunity" in volunteers. The Phase-2/3 data will give the final answer, but if it does not prove effective, Poonawalla says Serum Institute has backup candidates to move forward with. One of these is the shot from American biotech company Novavax.

    Share this timeline
    Facebook
    Whatsapp
    Twitter
    Linkedin
    Latest
    Oxford
    Vaccine
    Oxford University
    Bill & Melinda Gates Foundation

    Latest

    National Bagel Day 2023: Celebrate with these delectable recipes Food
    #NewsBytesExplainer: Decoding film studies—definition, general curriculum, famous film schools Bollywood Films
    5 recipes you can try on Makar Sankranti Makar Sankranti
    Mahindra Scorpio-N becomes costlier in India: Check new prices Mahindra Scorpio-N

    Oxford

    Cambridge Dictionary alters 'man' and 'woman' definitions, faces criticism Social Media
    Coronavirus vaccine consignment awaits government nod for take-off from Pune West Bengal
    All states to hold dry run for coronavirus vaccination today India
    Coronavirus: India's daily death toll remained under 300 last week India

    Vaccine

    US approves world's first vaccine for honey bees United States of America
    China slams 'distorted' Western reports on COVID-19 response, eases restrictions China
    Delhi: Government centers run out of free COVID-19 booster vaccine Delhi
    COVID-19: India logs 227 new cases, one death India

    Oxford University

    COVID-19 vaccine maker Professor Sarah Gilbert honored with Barbie doll Coronavirus
    AstraZeneca vaccine's single dose reduces death risk by 80%: Data Pfizer
    #OxfordUniversity racism row: India to raise the issue when required S Jaishankar
    Five killed in Serum Institute fire; Maharashtra government orders probe Narendra Modi

    Bill & Melinda Gates Foundation

    After divorce, Bill, Melinda Gates walk daughter down the aisle Bill Gates
    Bill Gates, Melinda French Gates are now officially divorced Bill Gates
    Bill and Melinda Gates consider organizational changes to Foundation Bill Gates
    Microsoft probed Bill Gates's affair with employee in 2019 Microsoft

    Love India News?

    Subscribe to stay updated.

    India Thumbnail
    Indian Premier League (IPL) Celebrity News Hollywood News Bollywood News UEFA Champions League Tennis Football Smartphones Cryptocurrency Upcoming Movies Premier League Cricket News Latest automobiles Latest Cars Upcoming Cars Latest Bikes Upcoming Tablets
    About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive Download DevBytes Find Cricket Statistics
    Follow us on
    Facebook Twitter Linkedin
    All rights reserved © NewsBytes 2023